Table 1.
General Characteristics of the 2 Groups of Patients
| COVID-19 | COVID-19 | p | |
|---|---|---|---|
| No (N = 21) | Yes (N = 17) | ||
| Characteristics | |||
| Women, N (%) | 12 (57) | 9 (53) | .79 |
| Age (years) | 87 ± 9 | 87 ± 8 | .96 |
| BMI (kg/m2) | 24.7 ± 5.6 | 26.2 ± 6.0 | .62 |
| Comorbidities, N (%) | |||
| Cardiovascular disease | 11 (52) | 11 (65) | .44 |
| Pulmonary disease | 3 (14) | 3 (18) | .78 |
| Cancer | 4 (19) | 3 (18) | .91 |
| Neurological disease | 8 (38) | 9 (53) | .36 |
| Diabetes mellitus | 7 (33) | 2 (12) | .12 |
| Hypertension | 15 (71) | 13 (76) | .73 |
| Medications | |||
| Number of chronic medications | 6.6 ± 3.2 | 6.4 ± 3.7 | .58 |
| Blood and kidney parameters | |||
| Lymphocytes (109/L) | 1.50 ± 0.50 | 0.91 ± 0.42 | <.001 |
| Leucocytes (109/L) | 6.49 ± 2.06 | 5.72 ± 2.21 | .27 |
| Hemoglobin (g/dL) | 12.0 ± 1.8 | 11.5 ± 1.8 | .41 |
| CRP (mg/L) | 17.9 ± 13.5 | 63.2 ± 53.2 | <.001 |
| Creatinine clearance (mL/min/1.73m2)a | 79.1 ± 21.1 | 74.1 ± 25.8 | .30 |
Notes: BMI = body mass index; CRP = C-reactive protein. Data are presented as mean ± SD.
aModification of diet in renal disease method.